• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Press release

Obducat receives order for NIL system from an Asian institute

Obducat

OBDUCAT has received an order for an EITRE 3 nanoimprint lithography (NIL) system. The order value amounts to approximately SEK 2.6 million and delivery is planned for the second quarter of 2026.

The institute will use the EITRE 3 system in research and development activities carried out through collaborations between academia and industry. The work is aimed at developing new innovative solutions within application areas including healthcare, agriculture, water and environmental technologies.

The research is conducted within the field of Bio-CPS (Bio Cyber Physical Systems), an interdisciplinary approach that combines biological sciences with electronics, computing and physical systems. By integrating these areas, the institute focuses on translating research into practical applications across several sectors. The EITRE 3 system provides the manufacturing capabilities needed to develop and evaluate small and precise structures that support this type of applied research.

For further information, please contact:
Henri Bergstrand, Chairman: +46 (0)46-10 16 00 or +46 (0) 708-88 72 45
Patrik Lundström, CEO: +46 (0)46 10 16 00 or +46 (0) 703 27 37 38


About Obducat AB (publ)
Obducat AB (publ) is an innovative developer and supplier of technologies, products and processes used for the production and replication of advanced micro and nano structures. Obducat's products and services serve the demands of customers worldwide within the LED and Display, Optics and Photonics, MEMS and Sensor industries as well as in High Power and High Frequency electronics and Biomedical Devices. Obducat's technologies include nano imprint technology, resist- and wet processing technologies. Obducat has its own market presence in Sweden, Germany, Japan, USA, England, Portugal and China and the headquarter is located in Lund, Sweden. Obducat is a public company. The Obducat share is traded on the Swedish NGM Main Regulated Equity exchange. Read more at www.obducat.com or contact us via email investorrelations@obducat.com


Attachments
Obducat receives order for NIL system from an Asian institute